Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Martial Arts | 3 | 2022 | 29 | 1.720 |
Why?
|
| Positive-Pressure Respiration | 7 | 2021 | 638 | 1.430 |
Why?
|
| Boxing | 2 | 2022 | 17 | 0.990 |
Why?
|
| Esophagus | 8 | 2021 | 1030 | 0.770 |
Why?
|
| Survival | 1 | 2021 | 160 | 0.760 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2021 | 120 | 0.710 |
Why?
|
| Respiration, Artificial | 6 | 2022 | 2622 | 0.630 |
Why?
|
| Weight Gain | 3 | 2022 | 2346 | 0.480 |
Why?
|
| Standard of Care | 1 | 2017 | 550 | 0.440 |
Why?
|
| Weight Loss | 2 | 2021 | 2683 | 0.410 |
Why?
|
| Pressure | 5 | 2019 | 1155 | 0.380 |
Why?
|
| Acute Lung Injury | 3 | 2009 | 367 | 0.380 |
Why?
|
| Hypnotics and Sedatives | 2 | 2022 | 1177 | 0.360 |
Why?
|
| Oxygen Consumption | 1 | 2013 | 1859 | 0.280 |
Why?
|
| Intensive Care Units | 6 | 2022 | 3742 | 0.270 |
Why?
|
| Hemodynamics | 2 | 2018 | 4167 | 0.230 |
Why?
|
| Body Mass Index | 1 | 2021 | 12932 | 0.210 |
Why?
|
| Cardiomyopathies | 3 | 2018 | 1957 | 0.200 |
Why?
|
| Reflex | 1 | 2024 | 376 | 0.200 |
Why?
|
| Manometry | 3 | 2009 | 454 | 0.200 |
Why?
|
| Competitive Behavior | 1 | 2021 | 78 | 0.180 |
Why?
|
| Capillary Permeability | 1 | 2024 | 773 | 0.180 |
Why?
|
| Athletic Performance | 1 | 2021 | 109 | 0.170 |
Why?
|
| Respiratory Mechanics | 4 | 2024 | 699 | 0.170 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 249 | 0.150 |
Why?
|
| Thoracic Wall | 2 | 2009 | 202 | 0.140 |
Why?
|
| Midodrine | 1 | 2017 | 24 | 0.140 |
Why?
|
| Athletes | 2 | 2022 | 1134 | 0.140 |
Why?
|
| Vasoconstrictor Agents | 2 | 2019 | 653 | 0.140 |
Why?
|
| Shock | 1 | 2019 | 314 | 0.140 |
Why?
|
| Fluid Therapy | 1 | 2021 | 580 | 0.140 |
Why?
|
| California | 1 | 2021 | 1426 | 0.140 |
Why?
|
| Angiotensin II | 1 | 2019 | 848 | 0.130 |
Why?
|
| Tracheostomy | 1 | 2020 | 426 | 0.130 |
Why?
|
| Propofol | 1 | 2022 | 603 | 0.130 |
Why?
|
| Internationality | 1 | 2021 | 1001 | 0.120 |
Why?
|
| Sepsis | 2 | 2018 | 2583 | 0.120 |
Why?
|
| Eating | 1 | 2021 | 1535 | 0.110 |
Why?
|
| Hypotension, Orthostatic | 1 | 2017 | 258 | 0.110 |
Why?
|
| Clinical Protocols | 2 | 2017 | 1438 | 0.110 |
Why?
|
| Hospital Costs | 1 | 2019 | 948 | 0.110 |
Why?
|
| Infection Control | 1 | 2020 | 985 | 0.110 |
Why?
|
| Conscious Sedation | 1 | 2017 | 532 | 0.110 |
Why?
|
| Postoperative Care | 1 | 2019 | 1471 | 0.110 |
Why?
|
| Perioperative Care | 1 | 2020 | 1034 | 0.100 |
Why?
|
| Patient Admission | 1 | 2019 | 1367 | 0.100 |
Why?
|
| Propensity Score | 1 | 2019 | 1906 | 0.100 |
Why?
|
| Critical Care | 2 | 2017 | 2697 | 0.090 |
Why?
|
| Body Weight | 1 | 2021 | 4614 | 0.090 |
Why?
|
| Delirium | 1 | 2022 | 1667 | 0.090 |
Why?
|
| Occupational Exposure | 1 | 2020 | 1811 | 0.090 |
Why?
|
| Length of Stay | 3 | 2019 | 6413 | 0.080 |
Why?
|
| Compliance | 1 | 2009 | 100 | 0.080 |
Why?
|
| Pleural Cavity | 1 | 2009 | 25 | 0.080 |
Why?
|
| Heart Arrest | 1 | 2019 | 1502 | 0.080 |
Why?
|
| Lung Compliance | 1 | 2009 | 200 | 0.080 |
Why?
|
| Protein C | 1 | 2009 | 133 | 0.080 |
Why?
|
| Humans | 29 | 2024 | 760437 | 0.080 |
Why?
|
| Shock, Septic | 2 | 2018 | 764 | 0.070 |
Why?
|
| Male | 16 | 2024 | 360035 | 0.070 |
Why?
|
| Sex Factors | 1 | 2021 | 10538 | 0.070 |
Why?
|
| Abscess | 1 | 2009 | 606 | 0.060 |
Why?
|
| Analgesia, Obstetrical | 1 | 2007 | 169 | 0.060 |
Why?
|
| Retrospective Studies | 5 | 2022 | 80430 | 0.060 |
Why?
|
| Inflammation | 1 | 2024 | 10746 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 1 | 2009 | 1703 | 0.060 |
Why?
|
| Anesthesia, Spinal | 1 | 2007 | 280 | 0.060 |
Why?
|
| Analgesia, Epidural | 1 | 2007 | 332 | 0.050 |
Why?
|
| Laryngeal Muscles | 1 | 2024 | 107 | 0.050 |
Why?
|
| Angiopoietin-2 | 1 | 2024 | 172 | 0.050 |
Why?
|
| Adult | 13 | 2024 | 220781 | 0.050 |
Why?
|
| Coronary Thrombosis | 1 | 2005 | 440 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3080 | 0.050 |
Why?
|
| Morphine | 1 | 2007 | 655 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3200 | 0.050 |
Why?
|
| Antifibrinolytic Agents | 1 | 2005 | 292 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2009 | 1400 | 0.050 |
Why?
|
| Middle Aged | 11 | 2024 | 220382 | 0.050 |
Why?
|
| Heart Valve Diseases | 1 | 2009 | 1037 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2024 | 696 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2021 | 54339 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2013 | 10075 | 0.050 |
Why?
|
| Electromyography | 1 | 2024 | 1392 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2005 | 1165 | 0.040 |
Why?
|
| Organizational Case Studies | 1 | 2019 | 301 | 0.040 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2009 | 1554 | 0.040 |
Why?
|
| Catecholamines | 1 | 2019 | 386 | 0.040 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2019 | 189 | 0.040 |
Why?
|
| Female | 14 | 2024 | 391875 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 15820 | 0.040 |
Why?
|
| Aerosols | 1 | 2020 | 631 | 0.040 |
Why?
|
| Lung | 3 | 2014 | 9973 | 0.040 |
Why?
|
| Adrenergic alpha-1 Receptor Agonists | 1 | 2017 | 18 | 0.040 |
Why?
|
| Risk Factors | 2 | 2021 | 74055 | 0.040 |
Why?
|
| Aged | 8 | 2024 | 168840 | 0.030 |
Why?
|
| Tidal Volume | 2 | 2008 | 487 | 0.030 |
Why?
|
| Benzodiazepines | 1 | 2022 | 1130 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2024 | 3209 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2005 | 2332 | 0.030 |
Why?
|
| Cytokines | 1 | 2007 | 7377 | 0.030 |
Why?
|
| Shock, Cardiogenic | 1 | 2018 | 708 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 10180 | 0.020 |
Why?
|
| Pulmonary Embolism | 1 | 2005 | 2563 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2019 | 989 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2007 | 3792 | 0.020 |
Why?
|
| Fallopian Tubes | 1 | 1990 | 177 | 0.020 |
Why?
|
| APACHE | 1 | 2009 | 267 | 0.020 |
Why?
|
| Heart Failure | 1 | 2013 | 11653 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2020 | 2517 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2017 | 4010 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2019 | 3008 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2017 | 12320 | 0.020 |
Why?
|
| Time Factors | 2 | 2020 | 39947 | 0.020 |
Why?
|
| Labor Pain | 1 | 2007 | 15 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6297 | 0.020 |
Why?
|
| Stomach | 1 | 2009 | 694 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2018 | 6380 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2020 | 64591 | 0.010 |
Why?
|
| Infertility, Female | 1 | 1990 | 758 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2019 | 3798 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2017 | 3436 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 5332 | 0.010 |
Why?
|
| Nausea | 1 | 2007 | 679 | 0.010 |
Why?
|
| Fentanyl | 1 | 2007 | 435 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 2009 | 1150 | 0.010 |
Why?
|
| Bupivacaine | 1 | 2007 | 412 | 0.010 |
Why?
|
| Artifacts | 1 | 2009 | 1898 | 0.010 |
Why?
|
| Prevalence | 1 | 2018 | 15698 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8623 | 0.010 |
Why?
|
| Anesthetics, Local | 1 | 2007 | 998 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 6525 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2020 | 23953 | 0.010 |
Why?
|
| Patient Selection | 1 | 2009 | 4240 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 6230 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29551 | 0.010 |
Why?
|
| Oxygen | 1 | 2008 | 4222 | 0.010 |
Why?
|
| Critical Illness | 1 | 2009 | 2722 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 41366 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2007 | 3546 | 0.010 |
Why?
|
| Linear Models | 1 | 2006 | 5865 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2008 | 8611 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 12054 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2009 | 4806 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 9462 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 15257 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 20078 | 0.010 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 1990 | 96 | 0.010 |
Why?
|
| Pregnancy | 1 | 2007 | 29831 | 0.000 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1990 | 662 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 58859 | 0.000 |
Why?
|
| Incidence | 1 | 1990 | 21322 | 0.000 |
Why?
|
Concepts
(151)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(36)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_